Market revenue in 2023 | USD 2.1 million |
Market revenue in 2030 | USD 12.0 million |
Growth rate | 28.1% (CAGR from 2023 to 2030) |
Largest segment | Drug optimization & repurposing |
Fastest growing segment | Drug Optimization & Repurposing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Optimization & Repurposing, Preclinical Testing |
Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Drug optimization & repurposing was the largest segment with a revenue share of 52.38% in 2023. Horizon Databook has segmented the UAE artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.
The adoption of AI in drug discovery is expected to grow exponentially for reducing time and cost associated with the process. Increase in government investments and number of healthcare organizations embracing AI is expected to boost the market over the coming years.
In May 2018, Abu Dhabi’s Department of Health announced a new strategy, called UAE Strategy for Artificial Intelligence, to regulate the implementation of AI and its use in healthcare. It is also raising funds for expansion, implementation.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into UAE artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account